PIP5K1A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.52549999801843E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.94139999999999E-05 |
Normal-vs-Stage2 |
2.863400E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.973700E-02 |
Stage1-vs-Stage2 |
2.377200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.804400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.045600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.56419999952639E-07 |
Normal-vs-AfricanAmerican |
9.83289999999526E-05 |
Normal-vs-Asian |
3.200900E-03 |
Caucasian-vs-AfricanAmerican |
7.325000E-01 |
Caucasian-vs-Asian |
5.225200E-01 |
AfricanAmerican-vs-Asian |
1.729170E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.771100E-04 |
Normal-vs-Female |
5.30480000038303E-07 |
Male-vs-Female |
7.928000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.846300E-02 |
Normal-vs-Extreme_Weight |
1.76607999999856E-05 |
Normal-vs-Obese |
3.574500E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.918600E-01 |
Normal_Weight-vs-Obese |
3.413800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
9.471200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.619600E-01 |
Normal-vs-Age(41-60Yrs) |
2.761500E-04 |
Normal-vs-Age(61-80Yrs) |
1.87680999998996E-05 |
Normal-vs-Age(81-100Yrs) |
2.183000E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.880100E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.139200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.188800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.060100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.789000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.500000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.187800E-01 |
Normal-vs-Grade 3 |
8.608800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.875000E-01 |
Grade 2-vs-Grade 4 |
9.187800E-01 |
Grade 3-vs-Grade 4 |
8.608800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.96539999947265E-07 |
Normal-vs-N1 |
1.571890E-02 |
N0-vs-N1 |
2.196000E-02 |
|
|